These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35302691)

  • 21. Screening for late-onset Pompe disease in Internal Medicine departments in Spain.
    López-Rodríguez M; Torralba-Cabeza MA; de Pedro IP; Rivera A; Gil RS; Gómez-Belda A; de la Peña JLP; de Los Santos Moreno A; Selva-O'Callaghan A; Gárate IG; García AG; Hurtado R; de Ureta PT; Barba-Romero MÁ; Milisenda JC; Grau-Junyent JM;
    Orphanet J Rare Dis; 2023 Aug; 18(1):256. PubMed ID: 37653444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Speech Disorders in Children With Pompe Disease: Articulation, Resonance, and Voice Measures.
    Neel AT; Crisp KD; Kishnani PS; Jones HN
    Am J Speech Lang Pathol; 2023 Jul; 32(4):1501-1516. PubMed ID: 37195639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of Pompe disease in China: a report from the Pompe registry.
    Zhao Y; Wang Z; Lu J; Gu X; Huang Y; Qiu Z; Wei Y; Yan C
    Orphanet J Rare Dis; 2019 Apr; 14(1):78. PubMed ID: 30943998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Yield of Chilaiditi's Sign in Advanced-Phase Late-Onset Pompe Disease.
    Takahashi J; Mori-Yoshimura M; Ariga H; Sato N; Nishino I; Takahashi Y
    J Neuromuscul Dis; 2022; 9(5):619-627. PubMed ID: 35964201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.
    Hensel O; Schneider I; Wieprecht M; Kraya T; Zierz S
    Orphanet J Rare Dis; 2018 Apr; 13(1):57. PubMed ID: 29653542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population.
    Lee JH; Shin JH; Park HJ; Kim SZ; Jeon YM; Kim HK; Kim DS; Choi YC
    Neuromuscul Disord; 2017 Jun; 27(6):550-556. PubMed ID: 28433475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.
    Rairikar MV; Case LE; Bailey LA; Kazi ZB; Desai AK; Berrier KL; Coats J; Gandy R; Quinones R; Kishnani PS
    Mol Genet Metab; 2017 Nov; 122(3):99-107. PubMed ID: 28951071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families.
    Napolitano F; Bruno G; Terracciano C; Franzese G; Palomba NP; Scotto di Carlo F; Signoriello E; De Blasiis P; Navarro S; Gialluisi A; Melone MAB; Sampaolo S; Esposito T
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case.
    Kobayashi H; Shimada Y; Ikegami M; Kawai T; Sakurai K; Urashima T; Ijima M; Fujiwara M; Kaneshiro E; Ohashi T; Eto Y; Ishigaki K; Osawa M; Kyosen SO; Ida H
    Mol Genet Metab; 2010 May; 100(1):14-9. PubMed ID: 20202878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial aneurysm management in patients with late-onset Pompe disease (LOPD).
    Mormina E; Musumeci O; Tessitore A; Ciranni A; Tavilla G; Pitrone A; Vinci SL; Caragliano AA; Longo M; Granata F; Toscano A
    Neurol Sci; 2021 Jun; 42(6):2411-2419. PubMed ID: 33067680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene Therapy for Pompe Disease: The Time is now.
    Colella P; Mingozzi F
    Hum Gene Ther; 2019 Oct; 30(10):1245-1262. PubMed ID: 31298581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity.
    Smith BK; Martin AD; Lawson LA; Vernot V; Marcus J; Islam S; Shafi N; Corti M; Collins SW; Byrne BJ
    Exp Neurol; 2017 Jan; 287(Pt 2):216-224. PubMed ID: 27453480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.
    Jones HN; Hobson-Webb LD; Kuchibhatla M; Crisp KD; Whyte-Rayson A; Batten MT; Zwelling PJ; Kishnani PS
    Mol Genet Metab; 2021 Jul; 133(3):261-268. PubMed ID: 34053870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractures in children with Pompe disease: a potential long-term complication.
    Case LE; Hanna R; Frush DP; Krishnamurthy V; DeArmey S; Mackey J; Boney A; Morgan C; Corzo D; Bouchard S; Weber TJ; Chen YT; Kishnani PS
    Pediatr Radiol; 2007 May; 37(5):437-45. PubMed ID: 17342521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study.
    Hahn SH; Kronn D; Leslie ND; Pena LDM; Tanpaiboon P; Gambello MJ; Gibson JB; Hillman R; Stockton DW; Day JW; Wang RY; An Haack K; Shafi R; Sparks S; Zhao Y; Wilson C; Kishnani PS;
    Genet Med; 2018 Oct; 20(10):1284-1294. PubMed ID: 29565424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for late-onset Pompe disease in western Denmark.
    Hansen JS; Pedersen EG; Gaist D; Bach FW; Vilholm OJ; Sandal B; Weitemeyer L; Nielsen K; Schlesinger FE; Preisler N; Vissing J; Andersen H
    Acta Neurol Scand; 2018 Jan; 137(1):85-90. PubMed ID: 28832912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease.
    Laforêt P; Laloui K; Granger B; Hamroun D; Taouagh N; Hogrel JY; Orlikowski D; Bouhour F; Lacour A; Salort-Campana E; Penisson-Besnier I; Sacconi S; Zagnoli F; Chapon F; Eymard B; Desnuelle C; Pouget J;
    Rev Neurol (Paris); 2013; 169(8-9):595-602. PubMed ID: 24008051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme.
    Pascual SI
    Adv Exp Med Biol; 2009; 652():39-46. PubMed ID: 20225018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-onset Pompe disease with left-sided bronchomalacia.
    Yang CF; Niu DM; Jeng MJ; Lee YS; Taso PC; Soong WJ
    Respir Care; 2015 Feb; 60(2):e26-9. PubMed ID: 25316892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).
    Montagnese F; Granata F; Musumeci O; Rodolico C; Mondello S; Barca E; Cucinotta M; Ciranni A; Longo M; Toscano A
    J Inherit Metab Dis; 2016 May; 39(3):391-398. PubMed ID: 26830551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.